Qube Research & Technologies LTD Gilead Sciences, Inc. Put Options Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $28.3 Million - $35.8 Million	-425,700 Reduced 92.64%	33,800 $2.83 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $21.6 Million - $24.9 Million	342,100 Added 291.4%	459,500 $31.5 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $8.6 Million - $10.5 Million	-120,100 Reduced 50.57%	117,400 $8.6 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $4.47 Million - $5.07 Million	61,000 Added 34.56%	237,500 $19.2 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $2.81 Million - $3.07 Million	38,000 Added 27.44%	176,500 $13.2 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $10.5 Million - $12 Million	138,500 New	138,500 $10.7 Million

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.